Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects

American Journal of Psychiatry

Volumn 156, Issue 11, 1999, Pages 1709-1719

  Pierri, Joseph N ^b   Chaudry, Adil S ^b   Woo, Tsung Ung W ^b   Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOPSY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MONKEY; NERVE CELL; NERVE ENDING; NERVE FIBER; NEUROPATHOLOGY; NEUROPSYCHIATRY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; AXONS; CARRIER PROTEINS; FEMALE; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; HALOPERIDOL; HUMANS; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; MALE; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; NEURONS; ORGANIC ANION TRANSPORTERS; PREFRONTAL CORTEX; PRESYNAPTIC TERMINALS; PYRAMIDAL CELLS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; THALAMUS;

EID: 0032744393     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Goldman-Rakic PS, Selemon LD: Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull 1997; 23:437-458
2. Lewis DA: Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 1997; 16:385-398
3. Bird ED, Spokes EGS, Iversen LL: Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia. Brain 1979; 102:347-360
4. Sherman AD, Davidson AT, Baruah S, Hegwood TS, Waziri R: Evidence of glutamatergic deficiency in schizophrenia. Neurosci Lett 1991; 121:77-80
5. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 1995; 52:258-266
6. 67 mRNA in a subpopulation of GABA neurons in the prefrontal cortex of schizophrenic subjects. Abstracts of the Society for Neuroscience 1998; 24:986
7. Benes FM, Snyder-Marie A, Vincent S, Khan Y: Up-regulation of GABA-A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 1996; 75:1021-1031
8. Woo T-U, Whitehead RE, Melchitzky DS, Lewis DA: A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 1998; 95:5341-5346
9. Peters A: Chandelier cells, in Cerebral Cortex, vol 1. Edited by Jones EG, Peters A. New York, Plenum Press, 1984, pp 361-380
10. DeFelipe J, Farinas I: The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. Prog Neurobiol 1992; 39:563-607
11. White EL: General organization of the cerebral cortex, in Cortical Circuits: Synaptic Organization and Cerebral Cortex: Structure, Function and Theory. Cambridge, Mass, Birkhäuser Boston, 1989, pp 5-18
12. Mirra SS, Meyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41:479-486
13. Glantz LA, Lewis DA: Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: regional and diagnostic specificity. Arch Gen Psychiatry 1997; 54:943-952
14. Erickson SL, Akil M, Levey Al, Lewis DA: Postnatal development of tyrosine hydroxylase-and dopamine transporter-immunoreactive axons in monkey rostral entorhinal cortex. Cereb Cortex 1998; 8:415-427
15. Daviss SR, Lewis DA: Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res 1995; 59: 81-96
16. Rajkowska G, Goldman-Rakic PS: Cytoarchitectonic definition of prefrontal areas in the normal human cortex, I: remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex 1995; 5:307-322
17. Minelli A, Brecha NC, Karschin C, DeBiasi S, Conti F: GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J Neurosci 1995; 15:7734-7746
18. Janicak PG, Davis JM, Preskorn SH, Ayd FJ: Principles and Practice of Psychopharmacotherapy. Baltimore, Williams & Wilkins, 1993
19. Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Sampson AR, Lewis DA: Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 1999; 156:1580-1589
20. Fleiss JL: The Design and Analysis of Clinical Experiments. New York, John Wiley & Sons, 1986
21. Melchitzky DS, Sesack SR, Lewis DA: Parvalbumin-immunoreactive axon terminals in monkey and human prefrontal cortex: laminar, regional and target specificity of type I and type II synapses. J Comp Neurol 1999; 408:11-22
22. Giguere M, Goldman-Rakic PS: Mediodorsal nucleus: areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys. J Comp Neurol 1988; 277:195-213
23. Fuster JM: The Prefrontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe. Philadelphia, Lippincott-Raven, 1997
24. Guillery RW, Herrup K: Quantification without pontification: choosing a method for counting objects in sectioned tissues. J Comp Neurol 1997; 386:2-7
25. Andreasen NC, Flashman L, Flaum M, Arndt S, Swayze V II, O'Leary DS, Ehrhardt JC, Yuh WTC: Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 1994; 272:1763-1769
26. Schlaepfer TE, Harris GJ, Tien AY, Peng LW, Lee S, Federman EB, Chase GA, Barta PE, Pearlson GD: Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry 1994; 151:842-848
27. Shelton RC, Karson CN, Doran AR, Pickar D, Bigelow LB, Weinberger DR: Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect. Am J Psychiatry 1988; 145:154-163
28. Selemon LD, Rajkowska G, Goldman-Rakic PS: Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995; 52:805-818
29. Pakkenberg B: Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol Psychiatry 1993; 34:768-772
30. DeFelipe J, Hendry SHC, Jones EG: Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex. Proc Natl Acad Sci USA 1989; 86:2093-2097
31. Lewis DA, Lund JS: Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor-and parvalbumin-immunoreactive populations. J Comp Neurol 1990; 293:599-615
32. Woo T-U, Miller JL, Lewis DA: Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry 1997; 154:1013-1015
33. Pierri JN, Edgar CL, Lewis DA: Somal size of pyramidal neurons in deep layer 3 of prefrontal cortex of subjects with schizophrenia (abstract). Schizophr Res 1999; 36:84
34. Lund JS, Lund RD, Hendrickson AE, Bunt AH, Fuchs AF: The origin of efferent pathways from the primary visual cortex, area 17, of the macaque monkey as shown by retrograde transport of horseradish peroxidase. J Comp Neurol 1975; 164:287-304
35. Gilbert CD, Kelly JP: The projections of cells in different layers of the cat's visual cortex. J Comp Neurol 1975; 163:81-105
36. Anderson SA, Classey JD, Condé F, Lund JS, Lewis DA: Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience 1995; 67:7-22
37. Lund JS, Lewis DA: Local circuit neurons of developing and mature macaque prefrontal cortex: golgi and immunocytochemical characteristics. J Comp Neurol 1993; 328:282-312
38. Bourgeois J-P, Goldman-Rakic PS, Rakic P: Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb Cortex 1994; 4:78-96
39. Mager S, Naeve J, Quick M, Labarca C, Davidson N, Lester HA: Steady states, charge movements, and rates for a cloned GABA transporter expressed in xenopus oocytes. Neuron 1993; 10:177-188
40. Isaacson JS, Solis JM, Nicoll RA: Local and diffuse synaptic action of GABA in the hippocampus. Neuron 1993; 10:165-175
41. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG: Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606-612
42. Pakkenberg B: Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990; 47:1023-1028
43. Manaye KF, Liang C-L, Hicks PB, German D, Young KA: Nerve cell numbers in thalamic anterior and mediodorsal nuclei are selectively reduced in schizophrenia. Abstracts of the Society for Neuroscience 1998; 24:1236
44. Popken GJ, Bunney WE Jr, Potkin SG, Jones EG: Neuron number and GABAergic and glutamatergic mRNA expression in subdivisions of the thalamic mediodorsal nucleus of schizophrenics. Abstracts of the Society for Neuroscience 1998; 24: 991
45. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, Barnes TRE, Hirsch SR: Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998; 65:446-453
46. Glantz LA, Lewis DA: Prefrontal cortical pyramidal neurons exhibit decreased dendritic spine density in subjects with schizophrenia. Arch Gen Psychiatry (in press)
47. Benson DL, Huntsman MM, Jones EG: Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys. Cereb Cortex 1994; 4:40-51